Shengtao Xu

Discovery of Novel Quinoline–Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity

Wenlong Li, Feijie Xu, Shuai Wen et al. · Journal of Medicinal Chemistry · 2018 · 120 citations · Full text

A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway

Shengtao Xu, Hong Yao, Shanshan Luo et al. · Journal of Medicinal Chemistry · 2017 · 105 citations

Medicinal Chemistry, Chemoprevention Strategy, Medicine +14

Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy

Hao Cai, Xiaojing Huang, Shengtao Xu et al. · European Journal of Medicinal Chemistry · 2015 · 99 citations · Full text

Medicinal Chemistry, Dual Inhibitors, Medicine +9

Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site

Wenlong Li, Shuai Wen, Honghao Sun et al. · European Journal of Medicinal Chemistry · 2018 · 83 citations · Full text

Combinatorial Chemistry, Anti-tubulin Agents, Medicinal Chemistry +12

Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates

Jie Liu, Qin Liu, Xue Yang et al. · Bioorganic & Medicinal Chemistry · 2013 · 73 citations · Full text

Medicinal Chemistry, Derivative (Chemistry), Derivatives +9